Common Contracts
5 similar Promissory Note contracts by Minerva Neurosciences, Inc., Luthringer Remy
PROMISSORY NOTEPromissory Note • July 17th, 2014 • Luthringer Remy • Pharmaceutical preparations • Delaware
WHEREAS, Sonkei Pharmaceuticals, Inc., a Delaware corporation (the “Company”) has agreed to sell 1,112,500 shares of Company stock (“Restricted Stock”) to Maker, pursuant to that certain Subscription Agreement, dated as of the date hereof (the “Grant Agreement”);
PROMISSORY NOTEPromissory Note • June 10th, 2014 • Minerva Neurosciences, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, Sonkei Pharmaceuticals, Inc., a Delaware corporation (the “Company”) has agreed to sell 1,112,500 shares of Company stock (“Restricted Stock”) to Maker, pursuant to that certain Subscription Agreement, dated as of the date hereof (the “Grant Agreement”);
PROMISSORY NOTEPromissory Note • June 10th, 2014 • Minerva Neurosciences, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, Minerva Neurosciences, Inc., a Delaware corporation (the “Company”) has agreed to sell 97,737 shares of Company stock (“Restricted Stock”) to Maker, pursuant to that certain Subscription Agreement, dated as of the date hereof (the “Grant Agreement”);
PROMISSORY NOTEPromissory Note • February 14th, 2014 • Minerva Neurosciences, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, Minerva Neurosciences, Inc., a Delaware corporation (the “Company”) has agreed to sell 97,737 shares of Company stock (“Restricted Stock”) to Maker, pursuant to that certain Subscription Agreement, dated as of the date hereof (the “Grant Agreement”);
PROMISSORY NOTEPromissory Note • February 14th, 2014 • Minerva Neurosciences, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, Sonkei Pharmaceuticals, Inc., a Delaware corporation (the “Company”) has agreed to sell 1,112,500 shares of Company stock (“Restricted Stock”) to Maker, pursuant to that certain Subscription Agreement, dated as of the date hereof (the “Grant Agreement”);
